On-Demand Webinar: Critical challenges that Physicians are facing during the Pandemic



We are pleased to invite you to access our webinar, “Critical challenges that Physicians are facing during the Pandemic – Data from a Large-Scale Study in Latin America”, organized by Fine Research jointly with  The Pharmaceutical Marketing Group.

Diego Casaravilla, CEO of Fine Research, talks about the results of this unprecedented work, with contributions from Laura Craig, VP, Client Success, Delvinia and Cozete Gelli, Qualitative Analyst, Fine Research.

The aim was to understand the main challenges faced by doctors in the midst of the pandemic. The research completed at the end of May 2020 involved large-scale fieldwork in 16 countries in LatAm, interviewing more than 5,000 doctors.

The main opinions and challenges facing professionals in the region have been analyzed, grouped into three main axes; evidence on the pandemic, impact of the pandemic in their professional work and future scenarios.

You will discover answers to:

– What are the new challenges for doctors?
– How has the number of patients changed?
– How has the current context impacted doctors emotionally?
– How has patient adherence changed for Cancer, HIV or Diabetes patients?
– How empathetic have pharmaceutical companies been?
– What future scenarios do HCPs imagine will be likely to happen?

Access your webinar here

Click here to access the full report


Read More

Using Artificial Intelligence to unveil HCPs emotional challenges in the COVID-19 era



Imagine that you need to run a large scale quant project on the impact of COVID-19 in the medical profession and specifically on doctors´ emotions.

You would like to field as quickly as possible and you are in the middle of the pandemic.

You do not have time for traditional qual research but you want to make sure that your future quant survey will not be losing any relevant angle.

What can you you do?  What if you use a moderator that can chat with over 80 doctors in 5 days?

Well, that is exactly what we did. We reached doctors with our Latin American Physician panel and have them chat with CRIS, the virtual moderator created by the Canadian company Delvinia and in a matter of days we got the insights we needed!

The most surprising thing was that our AI CRIS pal helped us to unveil some emotional dimensions such as the hard time Brazilian doctors have in calming their patients’ anxieties around the pandemic or the different kind of fears they are experiencing.

We thank CRIS and “his” (or “her”?) colleagues at Delvinia for making this project feasible.

You can download the qual data that CRIS helped to unveil and also the full quant report here!



Read More





In a project carried out three months before the outbreak began in Wuhan, with both citizens and health professionals from Brazil, Argentina, Mexico, Colombia, Venezuela and the United States, we collected information on health system priorities in the Americas.

The project showed in advance the expectations of the population in the face of an epidemic that they saw as a probable event, the little preparation of the different countries  (that would later be confirmed), both in Latin America and in the United States, and also the other epidemic situations of the region (dengue, zika, chikungunya, malaria, etc.), problems related to nutrition, obstacles faced by patients and the main challenges for health professionals.

This helps to define a more comprehensive view of the health system and its dilemmas from the perspective of citizens and those who practice medical activity.

This project to support Save The Children Mission for Venezuela, was possible due to the pro bono collaboration of Fine Research, Toluna Panels, Reckner Healthcare and Confirmit Software. It was also endorsed  by The Esomar Fondation, and selected for presentation at the next ESOMAR Conference in Latin America


Read More

ESOMAR includes Fine Research as an example of response to COVID-19 crisis





Amsterdam, April 1, 2020

ESOMAR issued an statement named The role of Data, Research and Insights community in supporting global crisis and post-crisis management of Covid19 measures.

It included a number of relevant recommendations and detailed a few examples of members who, be they large globally renowned agencies or local boutique agencies, are working tirelessly to increase insight and understanding of how the world around is being changed by the Covid19 outbreak. This research is, and will be, invaluable to facilitate and enable government and business leaders to evaluate and take effective decisions that strengthen public trust and confidence, overcome the crisis as quickly as possible, and reboot our economies.

Those examples included the 7 selected cases of actions taken by Ipsos, YouGov, Kantar, GfK, KASI, PEW , and Fine Research.

Regarding FINE, the satement details as follows:

Supporting Latin American healthcare systems with intelligence and insights

FINE Research is a leading independent data collection company in Latin America. It runs several panels which address healthcare professionals in Latin America and as a result is well placed to support the health care profession in these countries as they prepare for the Covid-19 pandemic progress through the region.

FINE Research has been using its evidence-based medicine information tool, mailing capabilities and survey community platform, to provide updated information on COVID-19 to the Healthcare community. It has offered free of charge research for any initiative coming from public ministries of these countries in order to ensure that health-care professionals are taking decisions to prepare for and mitigate the impact of the Covid-19 on Latin American healthcare care

FINE Research runs and funds an ongoing COVID-19 Monitor, with a first wave run on nearly 1000 physicians in 4 Latin American countries (Brazil, Mexico, Colombia and Argentina) specifically on the status of the healthcare system itself to determine what should be the action plan for decision-makers.

The research identified that a focus is needed on improving hospital infrastructure and citizen awareness of the symptoms and prevention strategies, establishes evidence of a probable underreporting of diagnoses of Covid-19 showing the need of an urgent expansion of the testing capability, and a higher physician support of policies in countries looking to implement strict lockdown measures to contain the spread of the virus.

The full statement is available here



Read More

COVID-19: Evidence and Insights about the COVID-19 impact in Latin America



ESPAÑOL               PORTUGUÊS                FULL REPORT                 WEBINAR

June 28, 2020

While the pandemic seems to have gone beyond the peek in many European countries and most of the restrictions have been relaxed, the situation is becoming increasingly worrying in Latin America.

WHO reported by the end of May that for the first time this region concentrated the largest number of new daily cases, outpacing the US and Europe. Brazil only is today the second country globally in terms of total infections.

Two months before the pandemic outbreak in Wuhan, at Fine Research we asked doctors in Latin America and in the US about how prepared these countries were to face an epidemic. In the light of what we know today, results became not only truly shocking but also tragically prophetic, confirming the ill-preparation that was already evident for most of the physicians across the Americas.

With the start of the pandemic, FINE, decided to start a series of projects on COVID-19. The objective of that program was to make available its research capabilities and the online physician survey platform to support the public, the medical community, institutions, companies and the health authorities with evidence and insights useful against the pandemic.

The initiative that was financed internally by FINE included conducting more than 10,000 interviews with health professionals in 16 Latin American countries.

The initiative was designed as an open and collaborative work so while it has been overall sponsored by the ESOMAR Foundation and Save The Children, have also received contributions from many companies and organizations. The list include: Confirmit, Delvinia, EBSCO HEALTH/DynaMed, Datum, Ipsos, Observatorio 87, PBG, Provokers, Unilever, The Pharmaceutical Marketing Group, YOUNIVERSAL, DIMM Magazine, Brazilian Association of Research companies (ABEP) and of individual researchers (ASBPM) as well as ESOMAR.

Toluna and Reckner Healthcare have supported the pre-pandemic survey, and M3 Global have brought on board an interesting global project for the Birmingham University aimed to improve COVID-19 testing which we included in this pro-bono program.

The topics were grouped into four main axes: evidence around COVID-19, assessment of public policies, insights about the impact in the medical practice and future post-pandemic scenarios.

Some of the key lessons have been:

1. By late May the region was polarized between those HCPs who believe that restrictions should be relaxed in a gradual and controlled manner and those who think that controls should be maintained or tightened.

2. The number of COVID-19 patients reported in the survey is line with public information reported by WHO, confirming that by late May, most affected countries were Brazil, Mexico, Peru, Ecuador, Panama and Chile. However, evidence of suspicious cases and testing suggests high levels of underreporting, particularly  in Brazil, Venezuela, Ecuador, Mexico and Panama. While tests are considered reliable, they are not enough. Thus, in most countries are not even covering patients at risks and with symptoms. Tests are also taking significant processing time for adequate diagnosis and screening of the network of infected contacts. If in the US and Europe, processing times of test are around 1-2 days, in LatAm the average is 4 days.

3. By late May most doctors saw Peru’s hospital resources as already collapsed, including the availability of hospitalization beds, IT areas and respirators. In Ecuador, Guatemala, Mexico, Brazil and Venezuela these resources were perceived as having a high short-term risk of collapse.

4. Despite the limitations of the hospital infrastructure, in most countries the LatAm region has improved it, compared to the results seen in March, with the significant exception of Brazil.

5 The majority of hospitalized patients have been people showing pre-existent pathologies, particularly Diabetes, Cardiological diseases or respiratory diseases.

6. In all countries, there is an abrupt drop in patients seen in general by HCPs, significantly affecting adherence in all kinds of diseases, including potential life threatening diseases such as Cancer, HIV, Diabetes, respiratory, cardiological or autoimmune diseases.

7. The main perceived risks for the doctors are associated with the lack of protective material and lack of protocols. Doctors need clear training not only for the treatment of COVID-19 and the use of protective equipment, but also for the care of all types of patients, whether in hospital, office or virtual.

8. The pandemic has emotionally affected doctors, and the vast majority say they suffer from one or more of the following effects: fear of infection, anxiety, tiredness, difficulty sleeping, isolation, anguish, uncertainty, or irritability.

9. Those who are in the front line are especially affected by fear of family and personal infection, pressure from the work environment, and fatigue.

10. The imagined post-pandemic future will imply an important impact on the physical and emotional health of the population, as well as a profound transformation of the health ecosystem and the modalities of medical care, with new protocols and an increased use of telemedicine.

The program is working in updating the evidence so please free to reach out if you have any relevant ideas or contributions to support this program at


Click here to access the full report

You can also access our On-Demand webinar free of charge around current medical practice:

Critical challenges that Physicians are facing during the Pandemic ‎


The results and inisghts realted to this progrom have been published in leading sites and media of 11 countries in the region including O Globo (Brazil), Exame (Brazil), Clarin (Argentina), Page 12 (Argentina), ABC (Paraguay), Excelsior (Mexico), Gestión (Peru), Proceso (Honduras), La estrella (Panamá) and (El Observador) Uruguay, as well as in ESOMAR (Netherlands). EphMRA (Switzerland), among others.


ESOMAR FOUNDATION (Amsterdam) – Webinar Fine Research & Save The Children

ESOMAR (Amsterdam)


EPhMRA (Switzerland)


Telam  (Argentina)  Agencia  de Noticias del estado

Diario Clarín (Argentina)

Diario Clarín (Argentina)

Pagina 12 (Argentina)

Pagina 12 (Argentina)

Codigo Salud (Argentina)

El Economista (Argentina)

O Globo (Brasil)

Exame (Brasil)

O Vale (Brasil)–diz-pesquisa.html

Portal Hospital (Brasil)

SEGS (Brasil)

Delvnia (Canada)

Ipsos (Colombia) 

Proceso (Honduras)

Excelsior (Mexico)

La estrella (Panama)

ABC (Paraguay)

Gestion (Peru)

El Observador (Uruguay)–202048184157

La Diaria (Uruguay)

Diario Libre (USA)

Agencia AFP (INT)




Read More

Looking Inside The Digital Qual ToolBox

With the COVID-19 restriction on in person research, digi-qual is certainly booming but what if you had a set of guidelines to make sure you get tthe most of these tools to leverage the qualitative revolution?

With the purpose to provide researcher such a toolbox Garnette Weber (I-tracks Canada) jointly with Dalila Antonacachi (Fine Argentina) and Claudia Mota (Fine Brazil) co-presented a  complete paper at ESOMAR LATAM 2019 in Sao Paulo, with tips to  run communities, virtual focus groups, video based online IDs, or TDIs with screen share.



Read More

Fine becomes first LatAm agency that wins an AIR – Achievement in Insight and Research Award

London, UK, Oslo, Norway, and New York, NY – 10 September 2019Confirmit today announced the winners of the 2019 AIR (Achievement in Insight and Research) Awards. The AIR Awards were created to recognise Confirmit customers who are driving the Market Research industry forward by demonstrating innovation and excellence to enhance business performance.

Ken Østreng, CEO at Confirmit, says of the programme: “Great research is at the heart of business decision making. We are delighted to recognise the people and businesses whose dedication to innovation and insight are driving the Market Research industry forward. Congratulations to all our winners, we are proud to be part of your stories.”

Diego Casaravilla, CEO of Fine Research said: “Thank you to Confirmit for this wonderful recognition which is a great motivation for the FINE team to continue working towards excellence. We are particularly proud to be the first Latin American company to have won an AIR award. We are also very excited to be recognised as a Judges’ Choice winner in the Project and Innovation category.”

The judges were Kristin Luck, Founder of ScaleHouse, Dangjaithawin Anantachai, Managing Director, INTAGE Thailand, and Vanessa Oshima, Founder and President of Heart Data inc.



In the picture Emilia Gomez from FINE ARGENTINA  and Flavia Abe from FINE BRAZIL receiving the prize at the Confirmit booth in Edinburgh at the 2019 Esomar Annual Conference


Read More

Fine Panel offers latest updates on Evidence Based Medicine for free to all Latin American Physicians

August, 2019.

Fine Research has signed an agreement with EBSCO Health that enables offering free of charge to all LatAm health professionals an advanced tool for professional updating in evidence-based medicine.

It includes therapeutic recommendations based on latest evidence, medical calculators and permanent updates of medical news in the different specialties.

Panel Members get access to a tool aimed exclusively at health professionals, curated by renowned international specialists working in institutions such as Cochrane Center, Leiden University Medical Center, Harvard Medical School, University of Massachusetts Medical School, and with the collaboration of the American College of Physicians.

DynaMed is currently used by leading regional institutions such as the Ministry of Health of Brazil, the Mexican Social Security Institute, the Cardiovascular Foundation of Colombia or Garraham Hospital in Argentina.

To access DynaMed, the health professional community can do so simply by entering through the Fine Panel app, accessible through Google Play and Apple Store.

In the context of COVID-19 outbreak, an open access to this topic can be seen at the link below

We are confident that this development will contribute to the professional enhancement  of our community of health practitioners throughout Latin America.

In addittion it also supports to create a positive engagement with qual and online research participants who receive a relevant professional benefit for being part of our panel community.

We currently have thousands of doctors actively using the app in Brazil, Mexico, Argentina and Colombia

Read More

Fine Research updates its privacy policy to adjust to Brazilian LGPD

Privacy notice

This Privacy Notice became effective on August 8, 2019, anticipating in one year the full execution of the new Brazilian legislation on data protection recently aproved, and also following requirements by GDPR and national regulations of the countries in which we develop our activities.

At Fine Research, we recognize the importance of protecting your personal information and undertake to process it responsibly and in accordance with the data protection laws applicable in all countries in which we operate.

In the normal course of its business activities, Fine Research using its own name or its registered trademark Fine Panel, collects, uses and sometimes shares information to perform its daily operations. This Privacy Notice describes the general privacy practices of Fine Research that apply to the collection and use of such personal information.

In describing our collection, use and exchange of information in this Notice, we refer to our collection and use of “Personal Information.”
“Personal information” as used in this notice is any information related to an identified or identifiable individual. Examples of personal information include first and last name, postal address, email address, payment information, IP address, other online contact information or telephone number.

We collect the information you voluntarily provide on the application forms on our site, as responses to the surveys we run and / or we may obtain information, including personal information, from third-party sources that comply with this privacy notice and / or from public websites.

The personal data of the participating respondents will not be shared in any way with third parties other than internal employees or hired suppliers working on research tasks, nor will they be linked to their responses in any of the surveys carried out. The only exception to this rule is in cases of public health in which is a plausible report of a health adverse event (AE) , and only in cases where respondents have previously agreed to share their data.

Your data can be transferred internationally to the different offices that are part of the Fine Research network, including subsidiaries of Fine do Brazil Pesquisas Ltda, Fine Research SRL (Argentina), FR Research SA de CV (Mexico), Fine Research Latinoamerica SA Sucursal Colombia and Fine Research Latin America SA (Uruguay)

We only use personal data to:

– invite respondents to access our available surveys

– give them access evidence-based medical content tools

– verify the validity of the identities and prevent fraud

– process rewards for participation

– provide warnings to researchers involved in Adverse Events (AE) and expressly set forth in this Notice

– to maintain business operations, as with the suppliers that work on our behalf and ensure that they adhere to the same practices as this privacy notice.

– as required by law or to respond to the legal process

– to develop business relationships with its clients, prospects and suppliers with whom we have a legitimate interest to interact

– in other cases with the express consent

If there is a need to use your data for a secondary purpose, we will provide you with a Notice of such use.

If you have questions or need more information on the legal basis on which we collect and use your personal information, contact us at

We do not share your personal information with third parties, except as indicated in this document.

Personal data collected by Fine Research can be stored and processed in any of the countries we operate including Brazil, Mexico, Colombia, Chile, Peru, Uruguay or Central America, as well as in US storage facilities. Storage locations are chosen to operate efficiently, improve performance and create redundancies to protect data in the event of a failure or other problem. We take steps to ensure that the data we collect under this Notice is processed in accordance with the provisions of this Notice and the requirements of applicable law, wherever the data is located.

Fine Research complies with the General Law on Data Protection, LGPD and GDPR regarding the collection, use and retention of personal information transferred from Brazil, the rest of Latin America, the European Union and the United States.

Fine Research uses a variety of technologies to effectively protect your personal data from unauthorized access, use or disclosure. While we implement safeguards designed to protect your information, we know that no security system is impenetrable due to the inherent nature of the Internet, but we will always use reasonable and adequate security procedures.

We will retain the personal information we collect from you when there is an ongoing legitimate business need (for example, to provide a service you have requested or to comply with applicable legal, tax or accounting requirements).

When we do not have a legitimate business need in progress to process your personal information, we will delete or anonymize your data or, if that is not possible (for example, because your personal information has been stored in backup files), then we will securely store the personal information and isolate it from any further processing until it is possible to delete it.


You can exercise your rights by contacting us at
We respond to all requests we receive from people who wish to exercise their data protection rights in accordance with the applicable data protection laws.


You can choose not to receive contacts by clicking “Unsubscribe” at the bottom of the email that received the invitations.

To exercise the rights of your stakeholders,

contact us at

Regional Data Protection Officer – Diego Casaravilla

Brazil Data Protection Officer – Sandra Miranda

Fine do Brasil Pesquisas Ltda – Avenida Paulista 2494, 7th floor, Sao Paulo Brazil
Fine Research SRL – Olazabal 1334, Ciudad Autonoma de Buenos Aires, Argentina


Read More